# Case Report: Scurvy—a modifiable cause of psychiatric refractoriness and lithium pharmacokinetic abnormalities in autism

**Authors:** Marie Geiser, Nicolas Guggisberg, Josephine Convertini, Severine Crettol, Nicolas Ansermot, Vincent Guinchat

PMC · DOI: 10.3389/fpsyt.2025.1741734 · Frontiers in Psychiatry · 2026-01-23

## TL;DR

A case report shows that scurvy, caused by vitamin C deficiency, can lead to psychiatric symptoms and affect lithium levels in someone with autism.

## Contribution

Highlights scurvy as a modifiable cause of psychiatric refractoriness and lithium pharmacokinetic changes in autism.

## Key findings

- Vitamin C deficiency was linked to behavioral dysregulation and subtherapeutic lithium levels.
- High-dose vitamin C supplementation led to rapid behavioral improvement and increased lithium concentrations.
- The case suggests a possible interaction between vitamin C status and lithium pharmacokinetics.

## Abstract

Scurvy, although rare in developed countries, can notably occur in individuals with extreme dietary selectivity, particularly those with neurodevelopmental disorders. We describe the case of an 18-year-old woman with autism spectrum disorder and severe intellectual disability who presented with severe behavioral dysregulation and limited response to multiple psychotropic regimens. Despite progressive lithium dose escalation, serum levels remained subtherapeutic. The turning point came with the diagnosis of profound vitamin C deficiency (ascorbic acid <1 µmol/L), prompting high-dose supplementation. Within days, the patient showed rapid behavioral improvement and a marked rise in serum lithium concentrations, necessitating dose reduction. First, nutritional deficiencies—particularly scurvy—can manifest primarily through psychiatric and behavioral symptoms in vulnerable populations, often resulting in misdiagnosis and polypharmacy. Second, although still speculative, we hypothesize that vitamin C status may affect lithium pharmacokinetics. This case underscores the importance of nutritional screening in refractory psychiatric presentations, particularly in individuals with restrictive diets, and highlights a potentially underrecognized interaction between vitamin C and lithium that warrants further investigation.

## Linked entities

- **Chemicals:** vitamin C (PubChem CID 54670067), ascorbic acid (PubChem CID 9888239), lithium (PubChem CID 28486)
- **Diseases:** scurvy (MONDO:0009412), autism spectrum disorder (MONDO:0005258)

## Full-text entities

- **Diseases:** psychiatric (MESH:D001523), neurodevelopmental disorders (MESH:D002658), autism spectrum disorder (MESH:D000067877), nutritional deficiencies (MESH:D044342), vitamin C deficiency (MESH:D001206), behavioral dysregulation (MESH:D021081), Scurvy (MESH:D012614), intellectual disability (MESH:D008607), autism (MESH:D001321)
- **Chemicals:** ascorbic acid (MESH:D001205), lithium (MESH:D008094)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12878650/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12878650/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12878650/full.md

---
Source: https://tomesphere.com/paper/PMC12878650